Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Magdi Elsallab, M.D.,Ph.D.

Concepts (37)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Magdi Elsallab's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Magdi Elsallab has written about over time.
Stem Cell Transplantation, 1 publications between 2018 and 2018, average publication date July 2018. Stem Cells, 2 publications between 2018 and 2018, average publication date September 2018. Biological Products, 1 publications between 2020 and 2020, average publication date January 2020. Europe, 1 publications between 2020 and 2020, average publication date January 2020. Legislation, Drug, 1 publications between 2020 and 2020, average publication date January 2020. Marketing, 1 publications between 2020 and 2020, average publication date January 2020. Antigens, CD19, 2 publications between 2020 and 2023, average publication date August 2021. Hematologic Neoplasms, 2 publications between 2020 and 2023, average publication date December 2021. Receptors, Antigen, T-Cell, 3 publications between 2020 and 2023, average publication date April 2022. T-Lymphocytes, 3 publications between 2021 and 2023, average publication date October 2022. Immunotherapy, Adoptive, 6 publications between 2020 and 2024, average publication date November 2022. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 1 publications between 2023 and 2023, average publication date February 2023. Graft vs Host Disease, 1 publications between 2023 and 2023, average publication date August 2023. Accreditation, 1 publications between 2024 and 2024, average publication date March 2024. United States, 3 publications between 2024 and 2024, average publication date April 2024. Adverse Drug Reaction Reporting Systems, 1 publications between 2024 and 2024, average publication date May 2024. Neoplasms, Second Primary, 1 publications between 2024 and 2024, average publication date May 2024. United States Food and Drug Administration, 2 publications between 2024 and 2024, average publication date May 2024.

To see the data from this visualization as text, click here.
Elsallab's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (37)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.